CF
PKBO

Cantor Fitzgerald’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Cantor Fitzgerald’s Portfolio PKBO Stock Details PKBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,034
Closed -$160K – 837
2022
Q3 		$160K Hold
16,034
– – ﹤0.01% 615
2022
Q2 		$158K Buy
+16,034
New +$158K ﹤0.01% 665

Other funds holding PKBO

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cantor Fitzgerald's PKBO Position: Q4 2022 in Review

Cantor Fitzgerald sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 16,034 shares — an estimated $160K sold.

Cantor Fitzgerald first reported a position in PKBO in Q2 2022 and held it in 2 quarters. The position peaked at $160K in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

  • Cantor Fitzgerald reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Cantor Fitzgerald sold 16,034 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $160K.
  • Cantor Fitzgerald first reported a position in Peak Bio, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Cantor Fitzgerald's Peak Bio, Inc. Common Stock position peaked at $160K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Cantor Fitzgerald's 13F filing for Q4 2022, filed 14 Feb 2023.